March 23, 2020
Nordic Nanovector Appoints Dr Dominic Smethurst as Interim Chief Medical Officer
Media
March 20, 2020
Oncopeptides provides update regarding COVID-19 impact on the melflufen clinical program
March 20, 2020
Vicore informs on clinical programs in relation to the current outbreak of COVID-19
March 20, 2020
Impact of corona virus (COVID-19) on Targovax’s operations
March 17, 2020
Orexo presents sales potential of the pharmaceutical pipeline and digital therapies during the Capital Markets Day
March 12, 2020
GenSight Biologics Reports Full Year 2019 Financial Results and provides an Outlook on 2020
March 12, 2020
Invitation to attend Orexo´s Capital Markets Day via teleconference
March 11, 2020
Targovax ASA: Fourth quarter 2019 results
March 11, 2020
Targovax ASA: Annual Report 2019
March 09, 2020
Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell Therapy